What is AARD's enterprise value?

AARD (AARD) reported enterprise value of $20.15M in Q1 2026.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

AARD AARD Enterprise value

Enterprise value at other companies

AbbVieABBV

$460.96B+24.7%

Relmada Therapeutics, Inc.RLMD

$163.63M-76.9%

Rhythm Pharmaceuticals, Inc.RYTM

$5.99B+78.4%

Aquestive Therapeutics, Inc.AQST

$460.11M+65.5%

Viking TherapeuticsVKTX

$3.81B-14.5%

ArvinasARVN

$599.29M+45.3%

Other financials

Income statement

See full

Revenue-—

Operating income-$22.5M-115%

Net income-$21.6M-132%

EPS (diluted)-$0.99-39.4%

Balance sheet

See full

Cash & equivalents$62.4M+136%

Total debt$336.0K-53.7%

Total equity$87.0M-42.3%

Total assets$98.6M-37.2%

Cash flow

See full

Operating cash flow-$18.9M-65.7%

CapEx--100%

Free cash flow-$16.8M-117%

Valuation

See full

Market cap$124.35M-58.6%

Returns & leverage

See full

Return on equity-58.8%—

Debt / equity0×0.0×

Current ratio8.1×-17.8×

Where this comes from

Calculated from AARD’s reported figures.

$82.2Mmarket cap+$336.0Ktotal debt−$62.4Mcash and equivalents=$20.15M

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AARD's enterprise value?: AARD (AARD) reported enterprise value of $20.15M in Q1 2026.
What does enterprise value mean?: Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.